P614: NOVEL SPLICE-SITE MUTATION IN PLCG2 ASSOCIATED WITH RESISTANCE TO BTK INHIBITORS
Main Authors: | Jialei Qi, Martin Wist, Eugen Tausch, Deyan Yordanov Yosifov, Anja Schade, Xiang Gao, Rashmi Priyadharshini Dheenadayalan, Christof Schneider, Sascha Endres, Daniel Mertens, Peter Gierschik, Stephan Stilgenbauer, Billy Michael Chelliah Jebaraj |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969360.69911.52 |
Similar Items
-
PB1912: BTK AND PLCG2 GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH RESISTANCE TO COVALENT BTK INHIBITOR
by: Ekaterina Likold, et al.
Published: (2023-08-01) -
From Biology to Therapy: The CLL Success Story
by: Deyan Y. Yosifov, et al.
Published: (2019-04-01) -
P670: ABSENCE OF BTK, BCL2, AND PLCG2 MUTATIONS IN RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER FIRST-LINE TREATMENT WITH FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V)
by: L. J. Croner, et al.
Published: (2022-06-01) -
P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBINED TIME-LIMITED TREATMENT WITH ANTI-CD20 ANTIBODY + IBRUTINIB, IDELALISIB OR VENETOCLAX IN THE GCLLSG CLL2-BAG, -BCG, -BIG AND -BIO PHASE-II TRIALS
by: Deyan Yosifov, et al.
Published: (2023-08-01) -
Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2
by: Qi Peng, et al.
Published: (2023-01-01)